Regulus Therapeutics Inc. buy Wells Fargo & Company
Start price
27.03.25
/
50%
€1.49
Target price
27.03.26
€5.57
Performance (%)
373.15%
End price
28.03.26
-
Summary
This prediction is currently being closed. With a performance of 373.15% the BUY prediction by Wells_Fargo___Compan is a big success. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regulus Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -0,68 % | 4,05 % | 2,21 % |
| iShares Nasdaq 100 | 0,99 % | 10,87 % | 38,04 % |
| iShares Nikkei 225® | 3,28 % | 13,47 % | 59,00 % |
| iShares S&P 500 | 0,62 % | 6,20 % | 26,15 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Regulus Therapeutics Inc. diskutieren
Regulus Therapeutics Inc. (NASDAQ: RGLS) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $6.00 price target on the stock, up previously from $3.00.
Ratings data for RGLS provided by MarketBeat
In the thread Trading Regulus Therapeutics Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten